Product Information
SYMPROIC 0.2 MG TABLET is a brand product labeled by BioDelivery Sciences International Inc, priced at $16.2558 per EA under NDC 59385004130. Its NADAC has been published 376 times since Jul 24, 2019.
FDA first approved this application on Mar 23, 2017.
Strength
.2 mg/1
Manufacturer
BioDelivery Sciences International IncNDC
59385004130
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NALDEMEDINE TOSYLATEApproval Type
New Drug (NDA)
FDA Application
NDA208854FDA Approved
3/23/2017
On Market Since
6/14/2019
Pharmacological Classes
Price Statistics
The NADAC for SYMPROIC 0.2 MG TABLET has been published 376 times since Jul 24, 2019, and over the history we have for it it has risen 41.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $16.2558 per EA |
|---|---|
| All-time high | $16.2809 (May 13, 2026) |
| All-time low | $11.4818 (Jul 24, 2019) |
| 52-week high | $16.2809 |
| 52-week low | $15.5044 |
| Median price | $13.9369 |
| Average price | $13.8377 |
| Largest weekly change | +6.0% (Jan 10, 2024) |
| Weeks tracked | 376 |
| Tracking since | Jul 24, 2019 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the naldemedine market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
BioDelivery Sciences International Inc manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
naldemedine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Opioid Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of SYMPROIC 0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for SYMPROIC 0.2 MG TABLET, manufactured by BioDelivery Sciences International Inc, is $16.2558 per EA (NDC 59385004130), effective Sep 30, 2026.
How has the price of SYMPROIC 0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for SYMPROIC 0.2 MG TABLET has risen 41.6%. It has been tracked across 376 weekly CMS publications since Jul 24, 2019.
What are the highest and lowest recorded NADAC prices for SYMPROIC 0.2 MG TABLET?
Since Jul 24, 2019, the NADAC for SYMPROIC 0.2 MG TABLET has ranged from a low of $11.4818 (Jul 24, 2019) to a high of $16.2809 (May 13, 2026), with a median of $13.9369 per EA.
Are there cheaper alternatives to SYMPROIC 0.2 MG TABLET?
No other NADAC-published product currently shares the active ingredient and strength of SYMPROIC 0.2 MG TABLET in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures SYMPROIC 0.2 MG TABLET?
SYMPROIC 0.2 MG TABLET (NDC 59385004130) is labeled by BioDelivery Sciences International Inc, and CMS classifies it as a brand product.